See more : Adslot Limited (ADS.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Aurora Cannabis Inc. (21P1.F) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aurora Cannabis Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- China CITIC Bank Corporation Limited (CHCJY) Income Statement Analysis – Financial Results
- S2 Resources Ltd (S2R.AX) Income Statement Analysis – Financial Results
- State Bank of India (SBID.L) Income Statement Analysis – Financial Results
- UNO Minda Limited (UNOMINDA.NS) Income Statement Analysis – Financial Results
- YCIH Green High-Performance Concrete Company Limited (1847.HK) Income Statement Analysis – Financial Results
Aurora Cannabis Inc. (21P1.F)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.auroramj.com
About Aurora Cannabis Inc.
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, Caribbeans, South America, and Israel; and distribution and sale of hemp-derived cannabidiol (CBD) products in the United States (U.S.) market. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, and cannabis extracts, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried milled strains and strain specific cannabis oils. Further, it offers patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 161.16M | 245.25M | 278.91M | 247.94M | 245.54M | 55.20M | 18.07M | 1.44M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 40.83K | 0.00 | 0.00 |
| Cost of Revenue | 174.65M | 266.81M | 312.45M | 88.12M | 103.10M | 11.68M | 2.01M | -762.97K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -13.49M | -21.56M | -33.54M | 159.82M | 142.44M | 43.52M | 16.06M | 2.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 40.83K | 0.00 | 0.00 |
| Gross Profit Ratio | -8.37% | -8.79% | -12.03% | 64.46% | 58.01% | 78.84% | 88.87% | 153.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% |
| Research & Development | 5.35M | 11.45M | 26.07M | 14.78M | 14.78M | 1.68M | 314.00K | 565.14K | 432.38K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 97.61M | 139.68M | 265.18M | 279.40M | 266.11M | 80.42M | 14.40M | 3.93M | 2.61M | 280.67K | 152.64K | 250.02K | 181.96K | 49.99K | 185.35K | 0.00 | 0.00 |
| Selling & Marketing | 42.36M | 55.20M | 91.27M | 99.29M | 99.27M | 29.45M | 10.27M | 1.71M | 1.02M | 0.00 | 142.94K | 61.27K | 18.97K | 7.20K | 0.00 | 0.00 | 0.00 |
| SG&A | 139.97M | 194.88M | 356.45M | 378.69M | 365.38M | 109.86M | 24.67M | 5.63M | 3.63M | 280.67K | 295.59K | 311.29K | 200.93K | 57.18K | 185.35K | 228.56K | 1.25K |
| Other Expenses | -3.14M | 6.13M | -28.64M | -3.26M | -3.26M | -907.00K | -1.14M | 0.00 | -5.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 171.41M | 225.09M | 450.93M | 456.84M | 443.50M | 123.63M | 25.70M | 6.79M | 4.37M | 306.49K | 402.88K | 330.79K | 201.33K | 57.77K | 186.18K | 229.05K | 1.25K |
| Cost & Expenses | 346.05M | 491.90M | 763.38M | 544.97M | 546.60M | 135.30M | 27.71M | 6.03M | 4.37M | 306.49K | 402.88K | 330.79K | 201.33K | 57.77K | 186.18K | 229.05K | 1.25K |
| Interest Income | 8.94M | 5.75M | 4.99M | 3.68M | 3.68M | 2.51M | 861.00K | 72.78K | 27.64K | 7.86K | 9.39K | 15.03K | 15.56K | 14.35K | 40.83K | 0.00 | 0.00 |
| Interest Expense | 35.60M | 66.44M | 77.54M | 41.03M | 39.41M | 2.28M | 1.29M | 619.12K | 177.41K | 101.08K | 0.00 | 0.00 | 745.00 | 484.00 | 310.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 93.66M | 98.08M | 114.89M | 88.26M | 12.26M | 1.09M | 593.22K | 304.80K | 303.00 | 432.00 | 422.00 | 409.00 | 583.00 | 834.00 | 490.00 | 0.00 |
| EBITDA | -135.76M | -137.20M | -393.23M | -214.66M | -218.70M | -78.46M | -12.98M | -4.75M | -9.24M | -298.33K | -402.45K | -330.36K | -185.36K | -57.18K | -144.52K | -228.56K | -1.25K |
| EBITDA Ratio | -84.24% | -55.94% | -140.99% | -86.58% | -89.07% | -142.14% | -71.86% | -329.96% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -353.91% | 0.00% | 0.00% |
| Operating Income | -189.32M | -282.82M | -490.96M | -314.24M | -318.28M | -95.77M | -11.19M | -4.59M | -4.37M | -298.63K | -402.88K | -330.79K | -202.08K | -58.25K | -145.35K | -229.05K | -1.25K |
| Operating Income Ratio | -117.48% | -115.32% | -176.03% | -126.74% | -129.63% | -173.51% | -61.95% | -318.96% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -355.95% | 0.00% | 0.00% |
| Total Other Income/Expenses | -539.73M | -392.46M | -2.83B | 6.14M | 6.14M | 168.08M | -1.90M | 89.08K | -5.06M | -101.08K | 9.39K | 15.03K | -167.26K | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -751.29M | -699.80M | -3.38B | -328.23M | -330.65M | 77.33M | -17.26M | -5.87M | -9.73M | -399.71K | -393.49K | -315.76K | -353.77K | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -466.18% | -285.34% | -1,213.27% | -132.38% | -134.66% | 140.09% | -95.56% | -408.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -13.44M | -6.32M | -83.40M | -30.31M | -29.91M | 8.10M | -4.30M | -148.84K | -207.71K | 0.00 | 0.00 | 0.00 | -31.28K | -13.86K | 310.00 | -51.76K | -1.27K |
| Net Income | -735.42M | -693.63M | -3.31B | -290.84M | -293.51M | 71.94M | -12.97M | -5.72M | -9.52M | -399.71K | -393.49K | -315.76K | -322.50K | -43.91K | -145.66K | -177.29K | 1.27K |
| Net Income Ratio | -456.34% | -282.82% | -1,186.90% | -117.30% | -119.54% | 130.33% | -71.78% | -397.67% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -356.71% | 0.00% | 0.00% |
| EPS | -0.37 | -4.10 | -33.94 | -3.63 | -3.66 | 1.88 | -0.56 | -0.53 | -1.48 | -0.30 | -0.29 | -0.24 | -0.24 | -0.04 | -0.12 | -0.19 | 0.01 |
| EPS Diluted | -0.37 | -4.10 | -33.94 | -3.63 | -3.66 | 1.83 | -0.56 | -0.53 | -1.48 | -0.30 | -0.29 | -0.24 | -0.24 | -0.04 | -0.12 | -0.19 | 0.01 |
| Weighted Avg Shares Out | 345.27M | 169.12M | 97.53M | 80.12M | 80.12M | 38.32M | 23.25M | 10.75M | 6.41M | 1.35M | 1.34M | 1.32M | 1.32M | 1.23M | 1.20M | 935.16K | 162.85K |
| Weighted Avg Shares Out (Dil) | 345.27M | 169.12M | 97.53M | 80.12M | 80.12M | 39.28M | 23.25M | 10.75M | 6.41M | 1.35M | 1.34M | 1.32M | 1.32M | 1.23M | 1.20M | 935.16K | 162.85K |
Source: https://incomestatements.info
Category: Stock Reports